Bard Mesh Settlement to Result in $21M Payment to Resolve 500 Cases: Report

Bloomberg News reports that C.R. Bard has agreed to pay $21 million to settle more than 500 vaginal mesh lawsuits. However, the medical device manufacturer continues to face nearly 10,000 more claims brought by women who allege they suffered painful and debilitating complications from the surgical mesh implants used to treat pelvic organ prolapse and stress urinary incontinence. 

Bard is one of several companies facing vaginal mesh and bladder sling lawsuits in courts nationwide, which involve more than 70,000 women throughout the United States who report experiencing problems when the mesh eroded through the vagina, caused infection or other severe problems, often resulting in the need for surgical removal of the mesh.

As hundreds of Bard mesh lawsuits are being prepared for early trial dates in the federal court system, a Bloomberg News report indicates that individuals familiar with the litigation say the company is willing to pay an average of more than $43,000 per claim to settle complaints.

Learn More About

Vaginal Mesh Lawsuits

Complications from transvaginal mesh may cause severe injuries.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

The Bard mesh settlement was first noted in a regulatory filing with the SEC in July, but details about the terms of the agreement were not released. However, even after the report of this agreement, the U.S. District Judge presiding over the litigation expressed frustration with the lack of progress being made to resolve the cases, indicating that he plans to speed up the vaginal mesh trial schedule and prepare continuing waves of cases for expedited trial dates throughout the country.

Vaginal Mesh Settlements and Trials

Most of those are Bard Avaulta mesh lawsuits which have been centralized before U. S. District Judge Joseph Goodwin in the Southern District of West Virginia, where 9,745 cases are consolidated as part of a federal multidistrict litigation (MDL).

In addition to cases against Bard, Judge Goodwin is also presiding over six other federal MDLs established for similar complaints filed against other manufacturers of transvaginal mesh and bladder sling products, including 13,853 Boston Scientific mesh lawsuits, 21,429 Ethicon mesh lawsuits, 18,784 American Medical Systems (AMS) mesh lawsuits, 1,682 Coloplast mesh lawsuits, 255 Cook Medical mesh lawsuits and 68 Neomedic mesh lawsuits.

All of the complaints involve similar allegations, indicating that the manufacturers designed and sold defective and unreasonably dangerous products, failing to adequately test the design or warn about the risk of vaginal mesh complications

Several early trial dates have already been held in courts throughout the country. While the manufacturers have had some success defending the lawsuits in individual trials, at least a half-dozen trials have resulted in multi-million dollar damage awards for plaintiffs, including several where juries added punitive damages designed to punish the manufacturers.

Known as “bellwether cases”, these trials are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely be repeated throughout the litigation. While the outcomes of the bellwether trials are not binding on other cases, they are designed to facilitate potential vaginal mesh settlement agreements that will avoid the need for thousands of trials to be scheduled in courts nationwide.

While Bard has reached some individual settlement agreements as mesh lawsuit came up for trial, the reported agreement to resolve 500 cases appears to be the first reached with individual attorneys to resolve their entire inventory of claims.

Endo International is the only manufacturer who has reached an agreement to settle nearly all of the cases it faces, reporting on September 30 that it has reached AMS mesh settlements that are expected to cost about $1.6 billion to resolve the litigation facing their subsidiary.

If Bard and other vaginal mesh manufacturers fail to reach more large scale settlements by the end of this year, it is expected that Judge Goodwin will begin remanding hundreds of cases back to U.S. District Courts nationwide for trials to be scheduled throughout 2015.

1 Comments

  • dakeysOctober 16, 2014 at 8:37 am

    How long is this going to continue ? Just pay up move on. Sick and tired of all of this bull. Over and over the same attorneys , the same judges. Enough is enough . Look go get the phone call the bank and the insurance company and stop making this worthless product. Butchers just keep on until there's no people life. Same old practices ancient history keep repeating. When Will you Humans Learn [Show More]How long is this going to continue ? Just pay up move on. Sick and tired of all of this bull. Over and over the same attorneys , the same judges. Enough is enough . Look go get the phone call the bank and the insurance company and stop making this worthless product. Butchers just keep on until there's no people life. Same old practices ancient history keep repeating. When Will you Humans Learn ! For God Sakes !

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.